Simply Oncology

Episode 86: The Metastatic Endometrial Cancer landscape with Dr Gemma Eminowicz (1/2)

John McGrane & Michael Rowe

Send us a text

Dr Gemma Eminowicz returns for 2026!!

Join us as we discuss the metastatic endometrial cancer landscape with Simply Oncology 'friend of the show' Dr Gemma Eminowicz from University College Hospital London.

Advanced endometrial cancer is so much more than carboplatin and paclitaxel. It now has the complete range of oncological treatments;

- Chemotherapy

- Immunotherapy

- Antibody Drug Conjugates

- Hormone therapy

- Targeted therapy

- Radiotherapy

We look at how the molecular testing in endometrial cancer has shaped advanced endometrial cancer therapy.

We look at the arrival of chemo-immunotherapy in the MMRd group and now in the MMRp patient group.

In the MMR proficient group we discuss the merits of 1st line Chemo-immunotherapy versus sequencing treatment to allow potential VEGF targeted therapy.

Gemma shares her invaluable experience and helps Mike understand advanced endometrial cancer. 


Enjoy!!